Conference
Efficacy and Safety of Benralizumab Compared with Mepolizumab in the Treatment of Eosinophilic Granulomatosis with Polyangiitis in Patients Receiving Standard of Care Therapy: Phase 3 MANDARA Study
Authors
Wechsler M; Nair P; Terrier B; Walz B; Bourdin A; Jayne D; Jackson D; Roufosse F; Sjo LB; Fan Y
Volume
153
Pagination
pp. AB364-AB364
Publisher
MOSBY-ELSEVIER
Publication Date
February 2024
Name of conference
Annual Meeting of the American-Academy-of-Allergy-Asthma-and-Immunology (AAAAI)
Conference place
DC, Washington
Conference start date
February 23, 2024
Conference end date
February 26, 2024
Conference proceedings
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
Issue
2
ISSN
0091-6749